US BROKER MOVES: CBOE upgraded at Morgan Stanley; DD downgraded at JPM

Newsquawk StaffPublished
Newsquawk headlinesUTC

Every headline is on the live feed 20 minutes before this site.

Canadian Part Time Employment Chg (Sep) -32.9K (Prev. -5.8K)

Canadian Participation Rate (Sep) 64.8% (Prev. 65.0%)

US BROKER MOVES: CBOE upgraded at Morgan Stanley; DD downgraded at JPM

Micron (MU) says it plans to construct new fabrication facilities and/or ramp production at existing fabrication facilities to increase supply in to respond to a significant increase in demand for memory products

Spanish Treasury announces plans to sell 2029, 2031 and 2033 bonds on October 15th

On the Newsquawk feed at , 20 minutes before this page.

Use the PlatformFree. No signup, no card.

UPGRADES

  • WeBull (BULL) Upgraded from Sector Perform to Sector Outperform at Scotiabank
  • Cboe Global Markets (CBOE) Upgraded from Underweight to Overweight at Morgan Stanley; PT USD 358
  • Elastic (ESTC) Upgraded from Neutral to Buy at Monness, Crespi, Hardt; PT USD 120
  • Fastly (FSLY) Upgraded from Perform to Outperform at Oppenheimer; PT USD 35
  • ICON (ICLR) Upgraded from Underperform to Neutral at BofA Securities; PT USD 185
  • Jack Henry & Associates (JKHY) Upgraded from Neutral to Overweight at Piper Sandler; PT USD 175
  • South Bow (SOBO) Upgraded from Underweight to Equalweight at Barclays; PT USD 33
  • VF Corp (VFC) Upgraded from Underweight to Neutral at JPMorgan; PT USD 18

DOWNGRADES

  • Alignment Healthcare (ALHC) Downgraded from Outperform to Market Perform at William Blair
  • Astera Labs (ALAB) Downgraded from Outperform to Market Perform at Northland
  • DuPont (DD) Downgraded from Overweight to Neutral at JPMorgan; PT USD 145
  • Gemini Space Station (GEMI) Downgraded from Equalweight to Underweight at Morgan Stanley; PT USD 4.75
  • Illinois Tool Works (ITW) Downgraded from Overweight to Neutral at JPMorgan; PT USD 277
  • Knife River (KNF) Downgraded from Outperform to Sector Perform at RBC Capital; PT USD 58
  • Pacira BioSciences (PCRX) Downgraded from Buy to Neutral at H.C. Wainwright; PT USD 36.50
  • Pluralsight (PS) Downgraded from Neutral to Sell at Citi; PT USD 45
  • Smithfield Foods (SFD) Downgraded from Buy to Neutral at BofA Securities; PT USD 21
  • Semtech (SMTC) Downgraded from Outperform to Market Perform at Northland
  • South Bow (SOBO) Downgraded from Equalweight to Underweight at Barclays; PT USD 33

INITIATIONS

  • BETA Technologies (BETA) Initiated at Overweight at Barclays; PT USD 35
  • Biogen (BIIB) Initiated at Outperform at CCB International
  • BellRing Brands (BRBR) Initiated at Outperform at BNP Paribas Exane; PT USD 12
  • Carrier Global (CARR) Initiated at Overweight at JPMorgan
  • C4 Therapeutics (CCCC) Initiated at Overweight at JPMorgan; PT USD 10
  • Ducommun (DCO) Initiated at Buy at Guggenheim; PT USD 246
  • Definium Therapeutics (DFTX) Initiated at Overweight at JPMorgan; PT USD 84
  • Duos Technologies (DUOT) Initiated at Neutral at Chardan; PT USD 9.50
  • Fortune Brands Innovations (FBIN) Initiated at Buy at Citi; PT USD 48
  • GSK (GSK) Initiated at Outperform at Wolfe Research; PT USD 70
  • IBM (IBM) Initiated at Hold at Truist Securities; PT USD 240
  • Karman Holdings (KRMN) Initiated at Overweight at Barclays; PT USD 79
  • LB Pharmaceuticals (LBRX) Initiated at Buy at Canaccord; PT USD 65
  • El Pollo Loco (LOCO) Initiated at Buy at Roth/MKM; PT USD 22
  • Macerich (MAC) Initiated at Outperform at BNP Paribas Exane; PT USD 28
  • Mobility Global (MBGL) Initiated at Equalweight at Morgan Stanley; PT USD 19
  • Mid Penn Bancorp (MPB) Initiated at Overweight at Piper Sandler; PT USD 42
  • Ovid Therapeutics (OVID) Initiated at Overweight at Cantor Fitzgerald
  • Plains All American Pipeline (PAA) Initiated at Buy at Jefferies; PT USD 27
  • Penguin Solutions (PENG) Initiated at Buy at BofA Securities; PT USD 100
  • Planet Labs (PL) Initiated at Equalweight at Barclays; PT USD 17
  • Quince Therapeutics (QNCX) Initiated at Outperform at Raymond James; PT USD 72
  • RMR Group (RMR) Initiated at Buy at Maxim Group; PT USD 26
  • Sanofi (SNY) Initiated at Peer Perform at Wolfe Research
  • Simon Property (SPG) Initiated at Neutral at BNP Paribas Exane; PT USD 222
  • Southwest Gas (SWX) Initiated at Peer Perform at Wolfe Research; PT USD 92
  • Trane Technologies (TT) Initiated at Overweight at JPMorgan
  • Vicore Pharma Holding AB (VCRE) Initiated at Buy at Jefferies; PT USD 25

Context

A clustered broker note day, with JPMorgan running a broad industrials reshuffle (downgrading DuPont and Illinois Tool Works to Neutral while initiating Carrier and Trane at Overweight) and Morgan Stanley lifting Cboe two notches to Overweight while cutting Gemini to Underweight. Two-name moves of this kind from a single house have historically mattered more than the headline count suggests: a double-step upgrade tends to force a sharper re-rating than a one-notch drift, because it signals a change of thesis rather than a mark-to-market. The distinction worth drawing is between calls that read as sector calls and those that read as single-stock: JPMorgan's pattern here, downgrading diversified industrials while initiating positively on climate-exposed machinery, is consistent with a published view on end-market mix rather than on any one name, and sector calls of that kind have tended to drive relative performance across the peer set for longer than idiosyncratic initiations. The South Bow anomaly, upgraded and downgraded at Barclays at the same price target on the same day, is almost certainly a data or syndication error of the sort that recurs in these roundups and is worth flagging rather than trading. Follow-ons that have historically mattered are whether the JPMorgan industrials stance is echoed by other houses at the next round of sector notes, and whether any of the initiations (IBM at Hold, the REIT pair at BNP Paribas Exane) coincide with earnings or guidance events that would give them more weight.

Related headlines

The feed had this first.

Use the Platform